THOMAS JAMES DOYLE - 28 Jan 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Issuer symbol
KURA
Transactions as of
28 Jan 2025
Net transactions value
-$38,958
Form type
4
Filing time
28 Jan 2025, 20:54:15 UTC
Previous filing
06 Jan 2025
Next filing
29 Sep 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $17,641 -2,241 -2.4% $7.87 90,901 28 Jan 2025 Direct F1
transaction KURA Common Stock Sale $6,982 -887 -0.98% $7.87 90,014 28 Jan 2025 Direct F2
transaction KURA Common Stock Sale $5,502 -699 -0.78% $7.87 89,315 28 Jan 2025 Direct F3
transaction KURA Common Stock Sale $8,832 -1,122 -1.3% $7.87 88,193 28 Jan 2025 Direct F4
holding KURA Common Stock 500 28 Jan 2025 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
F2 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
F3 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
F4 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.